Intercontinental Wealth Advisors, LLC Amgen Inc Transaction History

Intercontinental Wealth Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Jan 19, 2021	BUY	$234.65 - $260.95 $16,190 - $18,005	69 Added 8.25%	905 $175,000
Q2 2020 Jan 19, 2021	SELL	$197.81 - $242.74 $197 - $242	-1 Reduced 0.12%	836 $154,000
Q1 2020 Jan 19, 2021	BUY	$182.24 - $241.7 $33,532 - $44,472	184 Added 28.18%	837 $159,000
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $47,680 - $61,286	-252 Reduced 27.85%	653 $151,000
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $12,013 - $14,394	69 Added 8.25%	905 $175,000
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $166 - $195	-1 Reduced 0.12%	836 $154,000
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $149,320 - $174,305	837 New	837 $163,000
Q2 2017 Aug 09, 2017	SELL	N/A	-1,235 Closed	0 $0
Q1 2017 Mar 09, 2018	BUY	N/A	1,235 New	1,235 $203,000
Q4 2016 Mar 09, 2018	SELL	N/A	-1,293 Closed	0 $0
Q3 2016 Mar 12, 2018	BUY	N/A	1,293 New	1,293 $216,000
Q2 2016 Mar 09, 2018	SELL	N/A	-1,423 Closed	0 $0
Q1 2016 Mar 09, 2018	BUY	N/A	1,423	1,423 $213,000

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.